产品介绍
SLU-PP-332 is a selective Rev-ErbA agonist that modulates circadian rhythm-related metabolic pathways, acting on nuclear receptors involved in lipid metabolism, energy expenditure, and mitochondrial function. Research indicates it promotes fat oxidation, enhances exercise endurance capacity, and supports mitochondrial biogenesis while reducing fat mass without affecting lean muscle tissue. It is generally well-tolerated in research settings, though human clinical data remains limited, long-term safety is still under investigation, and potential interactions with circadian-sensitive medications should be considered. It is considered ideal for studies on metabolic regulation, fat oxidation, exercise performance, circadian biology, and body composition. This content is for research purposes only and is provided solely for reference. It must not be interpreted as health, clinical, or legal advice or guidance.
